Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 30% ± 14% | |
| glutamatergic neuron | 4 studies | 30% ± 11% | |
| ciliated cell | 3 studies | 23% ± 7% | |
| fibroblast | 3 studies | 20% ± 5% | |
| GABAergic neuron | 3 studies | 27% ± 6% | |
| dendritic cell | 3 studies | 24% ± 3% | |
| basal cell | 3 studies | 27% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 25% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 707.96 | 1445 / 1445 | 100% | 15.44 | 183 / 183 |
| ovary | 100% | 1185.36 | 180 / 180 | 100% | 21.64 | 430 / 430 |
| stomach | 100% | 624.58 | 359 / 359 | 100% | 17.70 | 286 / 286 |
| brain | 100% | 875.12 | 2639 / 2642 | 100% | 27.41 | 705 / 705 |
| lung | 100% | 807.43 | 577 / 578 | 100% | 19.12 | 1154 / 1155 |
| breast | 100% | 836.37 | 459 / 459 | 100% | 18.73 | 1114 / 1118 |
| thymus | 100% | 956.82 | 653 / 653 | 100% | 25.05 | 602 / 605 |
| bladder | 100% | 840.90 | 21 / 21 | 99% | 16.99 | 501 / 504 |
| uterus | 100% | 895.89 | 170 / 170 | 99% | 19.47 | 456 / 459 |
| prostate | 100% | 878.71 | 245 / 245 | 99% | 14.88 | 498 / 502 |
| intestine | 100% | 769.34 | 966 / 966 | 99% | 18.90 | 521 / 527 |
| pancreas | 99% | 460.68 | 326 / 328 | 99% | 16.05 | 176 / 178 |
| adrenal gland | 100% | 921.51 | 258 / 258 | 98% | 13.40 | 226 / 230 |
| skin | 100% | 983.56 | 1808 / 1809 | 98% | 14.96 | 461 / 472 |
| liver | 100% | 667.52 | 225 / 226 | 97% | 13.67 | 393 / 406 |
| kidney | 100% | 785.53 | 89 / 89 | 95% | 18.00 | 860 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 23.21 | 29 / 29 |
| spleen | 100% | 1043.69 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.09 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.82 | 1 / 1 |
| adipose | 100% | 769.72 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 732.58 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 430.30 | 789 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 17.12 | 78 / 80 |
| heart | 97% | 546.02 | 832 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 75% | 585.67 | 693 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0006457 | Biological process | protein folding |
| GO_0000413 | Biological process | protein peptidyl-prolyl isomerization |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
| Gene name | PPIL3 |
| Protein name | Peptidylprolyl isomerase (Cyclophilin)-like 3, isoform CRA_c (Peptidylprolyl isomerase-like 3 isoform B) (Peptidylprolyl isomerase-like protein 3 isoform PPIL3d) Peptidylprolyl isomerase like 3 Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3) Peptidylprolyl isomerase-like 3 isoform 2 |
| Synonyms | hCG_16559 |
| Description | FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. May be involved in pre-mRNA splicing. FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . |
| Accessions | A0A0S2Z5X8 ENST00000706563.1 Q9H2H8 F8WC82 A0A0S2Z5A8 C9J4N2 ENST00000415562.5 A0A9L9PX21 ENST00000409449.5 [Q9H2H8-2] ENST00000286175.12 [Q9H2H8-2] C9K058 ENST00000706562.1 A0A9L9PXN9 ENST00000457063.1 B8ZZ77 ENST00000409264.6 H7BZ14 Q86UR0 A0A9L9PY51 ENST00000392283.9 [Q9H2H8-1] ENST00000706564.1 ENST00000443398.5 ENST00000409361.5 A0A024R3V4 |
